The product is indicated in the treatment of the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.
Latanoprost + Timolol is currently available as Xalacom (Latanoprost + Timolol) from Pfizer and is available immediately in the Teva 360 livery, the company said.
Teva commercial director Kim Innes said they will continue with strong product launches and this is their second new product launch for this year.